Wearable Sweat Sensor Pioneer Issued Key Device Patent
CINCINNATI--(BUSINESS WIRE)--Dec 18, 2018--Eccrine Systems, Inc., an advanced sweat sensor company, today announced that a key patent, US10136831, has been issued to Dr. Jason Heikenfeld, Co-Founder & CSO, and prominent University of Cincinnati researcher. The company holds exclusive rights to the UC patent.
The patented invention covers the use of on-body sweat devices that are capable of electronically correlating two or more measurements of an analyte with the time at which the analyte emerged in newly excreted sweat. Without the use of the invention it is likely not possible to correlate sweat analyte data trends with chronological blood values or similar physiological measurements. Heikenfeld developed his invention over four years ago at a time when continuous on-body measurement of sweat analytes was at its inception. Heikenfeld is a well-known scientific leader of the wearable sweat sensor space with many of its most prescient and important advances to his credit.
The company uses Heikenfeld’s invention to time correlate the data derived from its sweat sensor devices, including data and algorithms that will define the pharmacokinetic (PK) profile of medications that are excreted in locally stimulated sweat. “Non-invasive medication monitoring is a great example of the utility of Jason’s invention,” says Dr. Gavi Begtrup, CEO of Eccrine Systems. “You can’t devise an on-body device to derive a sweat pharmacokinetic curve, and then correlate that curve to a drug’s blood PK curve, without using this invention. This is a big deal given the estimated $500 billion annual healthcare cost of non-optimized medication therapy, a significant portion of which can result from individual PK differences that cause failed treatment outcomes.”
About Eccrine Systems, Inc.
Eccrine Systems is a privately held company dedicated to improving human health, safety, and productivity through the innovation and development of advanced sweat sensing technologies. The Cincinnati-based company was founded in 2013 to commercialize technology and intellectual property that was exclusively licensed from the University of Cincinnati, and with the funding support of CincyTech and its network of local, regional and national investment sources. To learn more, please visit www.eccrinesystems.com.
Eccrine Systems and the company logo image are registered trademarks of Eccrine Systems, Inc.
Safe Harbor Statement
Some of the statements made in this press release are forward-looking statements about Eccrine Systems, Inc. These forward-looking statements are based upon the company’s current expectations and projections about future events and generally relate to the company’s plans, objectives and expectations for the development of its business. Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181218005089/en/
CONTACT: Eccrine Systems, Inc.
Evyn White, 513-214-1659
KEYWORD: UNITED STATES NORTH AMERICA OHIO
INDUSTRY KEYWORD: TECHNOLOGY OTHER TECHNOLOGY HEALTH BIOTECHNOLOGY MEDICAL DEVICES PHARMACEUTICAL OTHER HEALTH RESEARCH OTHER SCIENCE SCIENCE GENERAL HEALTH
SOURCE: Eccrine Systems, Inc.
Copyright Business Wire 2018.
PUB: 12/18/2018 08:45 AM/DISC: 12/18/2018 08:46 AM